Hormonal Regulation of Nitric Oxide (NO) in Cardio-metabolic Diseases

By  

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1427-1434

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of the Na+,K+-ATPase and its inhibitors in cardiovascular diseases

By Quadri L.   Ferrandi M.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 1, 1998-01 ,pp. : 39-52

Informa Healthcare

Access to resources Recommend Favorite

Discovery of steroid glycosides with selective inotropic action using Na+/K+-ATPase isoforms expressed in 'receptor blasts'. Selective inhibition of a1-isoform of Na+/K+-transporting ATPase (Na+/K+-ATPase) in cardiac muscle of man.

By Repke K.   Megges R.   Repke H.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 81-83

Informa Healthcare

Access to resources Recommend Favorite

Ral-GTPase interacts with the β1 subunit of Na⁺/K⁺-ATPase and is activated upon inhibition of the Na⁺/K⁺ pump

By Bhullar Rajinder P.   Clough Richard R.   Kanungo Juddy   Elsaraj Sherif M.   Grujic Ognjen  

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 3-4, 2007-03 ,pp. : 444-454

NRC Research Press

Access to resources Recommend Favorite

Modulators of Na/K-ATPase: a patent review

By Wang Hua-Yu Leo   O’Doherty George A  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 587-605

Informa Healthcare

Access to resources Recommend Favorite